P53 expression in adenomyosis in endometrial carcinoma patients

Gynecologic Oncology

Volumn 62, Issue 2, 1996, Pages 241-246

  Taskin, Metin ^a   Lallas, Thomas A ^a   Shevchuk, Maria ^a   Barber, Hugh R K ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOMYOSIS; ADULT; AGED; ARTICLE; CANCER INVASION; CARCINOMA IN SITU; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; EPITHELIUM DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030220214     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0222     Document Type: Article

References (17)

1. 1. Marcus, C. C. Relationship of adenomyosis uteri to endometrial hyperplasia and endometrial carcinoma, Am. J. Obstet. Gynecol. 82, 408-416 (1961).
2. 2. Sidawy, M. K., and Silverberg, S. G. Endometrial carcinoma: Pathologic factors of therapeutic and prognostic significance, Pathol. Ann. 2, 153-185 (1991).
3. 3. Mittal, K. R., and Barwick, K. W. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis, Gynecol. Oncol. 49, 197-201 (1993).
4. 4. Kohler, M. K., Berchuck, A., Davidoff, A. M., Humphrey, P. A., Dodge, R. K., Iglehart, J. D., Soper, J. T., Clarke-Pearson, D. L., Bast, R. C., Jr., and Marks, J. R. Overexpression and mutation of P53 in endometrial carcinoma, Cancer Res. 52, 1622-1627 (1992).
5. 5. Yu, C. C-W., Wilkinson, N., Brito, M. J., Fox, H., and Levison, D. A. Patterns of immunohistochemical staining for proliferating cell nuclear antigen and P53 in benign and neoplastic human endometrium, Histopathology 23, 367-371 (1993).
6. 6. Amros, R. A., Vigna, P. A., Figge, J., Kallakury, B. V. S., Mastrangelo, A., Eastman, Y. A., Malfetano, J., Figge, H. L., and Ross, J. S. Observation on tumor and metastatic supressor gene status in endometrial carcinoma with particular emphasis on P53, Cancer 73, 1686-1692 (1994).
7. 7. Elias, J. M., Margiotta, M., and Gabore, C. Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase labelled avidin-biotin (LAB) methods, Am. J. Clin. Pathol. 92, 62-67 (1989).
8. 8. Fukamatsu, Y., Tsukahara, Y., and Fukuta, T. A clinicopathologic study on adenomyosis uteri, Acta Obstet. Gynaecol. Jpn. 36, 431-436 (1984).
9. 9. Hayata, T., Kawashima, Y. Clinicopathologic study of eight cases of uterine body cancers associated with endometriosis interna (uterine adenomyosis), Am. J. Obstet. Gynecol. 156, 663-666 (1987).
10. 10. Giammalvo, J. T., and Kaplan, K. The incidence of endometriosis interna in 120 cases of carcinoma of the endometrium, Am. J. Obstet. Gynecol. 75, 161-165 (1958).
11. 11. Hernandez, E., and Woodruff, D. J. Endometrial adenocarcinoma arising in adeomyosis, Am. J. Obstet. Gynecol. 138, 827-832 (1980).
12. 12. Hall, J. B., Young, R. H., and Nelson, J. H. The prognostic significance of adenomyosis in endometrial carcinoma, Gynecol. Oncol. 17, 32-40 (1984).
13. 13. Levine, A. J., Momand, J., and Finlay, C. A. The P53 tumour supressor gene, Nature 351, 453-456 (1991).
14. 14. Purdie, C. A., O'Grady, J., Piris, J., Wyllie, A. H., and Bird, C. C. P53 expression in colorectal tumors, Am. J. Pathol. 138, 807-813 (1991).
15. 15. Koshiyama, M., Konishi, I., Wang, D., Mandai, M., Komatsu, T., Yamamoto, S., Nanbu, K., Naito, M. F., and Mori, T. Immunohistochemical analysis of P53 protein ooverexpression in endometrial carcinomas: Inverse correlation with sex receptor status, Virchows Arch. A Pathol. Anat. 423, 263-271 (1993).
16. 16. Colman, H., and Rosenthal, A. H. Carcinoma developing in areas of adenomyosis, Obstet. Gynecol. 14, 342-348 (1959).
17. 17. Jacques, S. M., and Lawrence, D. L. Endometrial carcinoma with variable level myometrial involvement limited to adenomyosis: A clinicopathologic study of 23 cases, Gynecol. Oncol. 37, 401-407 (1990).